Special Issues

Current Oncology publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process. The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue policies and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.

Section
Search by Title/Keyword
 
Order results
Display
Results per page
Advances in Radiation Treatment for Brain Tumors
edited by Andra Krauze
submission deadline 15 Dec 2025 | Viewed by 86 | Submission Open
Keywords: personalized treatment; artificial intelligence; automation; segmentation; adaptive treatment; immune modulation; fed-erated learning; multi-omics
(This special issue belongs to the Section Neuro-Oncology)
Novel Therapies for B-Cell Lymphomas
edited by David MacDonald
submission deadline 15 Dec 2025 | Viewed by 49 | Submission Open
Keywords: B-cell lymphomas; non-Hodgkin lymphomas; targeted therapy; CAR-T cell therapy; bispecific antibodies; biomarker-driven treatment; translational research; clinical trials
(This special issue belongs to the Section Hematology)
New and Emerging Trends in Prostate Cancer
edited by and Steven Tisseverasinghe
submission deadline 31 Dec 2025 | 6 articles | Viewed by 7921 | Submission Open
Keywords: prostate SBRT; recurrent prostate cancer; treatment intensification with ARPIs; PARP inhibitors; lutetium-177; immunotherapy; oligometastases
(This special issue belongs to the Section Genitourinary Oncology)
Pathways to Recovery and Resilience in Breast Cancer Survivorship
edited by Nazanin Derakhshan
submission deadline 31 Dec 2025 | 1 articles | Viewed by 5477 | Submission Open
Keywords: breast cancer; intervention; mixed methods; digital health; personalized care; AI; resilience; anxiety; depression; neuroscience
(This special issue belongs to the Section Psychosocial Oncology)
Optimizing Surgical Management for Gynecologic Cancers
edited by Jacob D. McGee
submission deadline 31 Dec 2025 | 2 articles | Viewed by 2821 | Submission Open
Keywords: pre-operative optimization; de-escalation; surgical approach; risk stratification; quality of Life; novel techniques
(This special issue belongs to the Section Gynecologic Oncology)
Advanced Research on Breast Cancer Genes in Cancers
edited by Andrea Eisen
submission deadline 31 Dec 2025 | 2 articles | Viewed by 1617 | Submission Open
Keywords: breast cancer genes; BRCA1/2 mutations; cancer genomics; targeted therapies; precision medicine; genetic counseling
(This special issue belongs to the Section Oncology Biomarkers)
2nd Edition—Haematological Neoplasms: Diagnosis and Management submission deadline 31 Dec 2025 | 1 articles | Viewed by 1016 | Submission Open
Keywords: myeloid neoplasms; lymphoid neoplasms; pathology; molecular biology; precision medicine; biomarkers
(This special issue belongs to the Section Hematology)
Recent Advances in Immune Checkpoint Inhibition and Antibody Drug Conjugates in Urothelial Carcinoma
edited by Qian Janie Qin
submission deadline 31 Dec 2025 | 1 articles | Viewed by 828 | Submission Open
Keywords: immune checkpoint inhibition; antibody drug conjugates; urothelial carcinoma; therapeutic combinations; biomarkers; resistance mechanisms; treatment efficacy; cancer immunotherapy
(This special issue belongs to the Section Genitourinary Oncology)
Clinical Advances in Thyroid Cancer: Biomarker-Driven Diagnosis, Oncogenesis Insights, and Translational Therapies
edited by Salma Khan
submission deadline 31 Dec 2025 | 1 articles | Viewed by 515 | Submission Open
Keywords: thyroid cancer; oncogenesis; translational therapies; fine-needle aspiration (FNA); precision medicine; targeted therapy
(This special issue belongs to the Section Head and Neck Oncology)
Psychological Interventions for Cancer Survivors
edited by Christian Schulz-Quach
submission deadline 31 Dec 2025 | Viewed by 176 | Submission Open
Keywords: cancer survivors; psychological interventions; mental health; quality of life; existential– phenomenological approaches; relational frameworks; resilience; evidence-based therapies; post-treatment care
(This special issue belongs to the Section Psychosocial Oncology)
Combining Radiotherapy and Immunotherapy for Cancer Treatment
edited by Yufei Liu
submission deadline 31 Dec 2025 | Viewed by 164 | Submission Open
Keywords: radiation oncology; immunotherapy; immunomodulation; immune checkpoint inhibitors; abscopal effect; stereotactic body ra-diation therapy; antibody– drug conjugate; CAR-T cell therapy; tumor-infiltrating lymphocytes
(This special issue belongs to the Section Thoracic Oncology)
2nd Edition—Chronic Lymphocytic Leukemia: Therapy and Outcome
edited by
submission deadline 31 Dec 2025 | Viewed by 66 | Submission Open
Keywords: chronic lymphocytic leukemia; microenvironment; BTK inhibitors; BCL2 inhibitors; PI3K inhibitors; infection; prognostic factors; predictive factors; richter syndrome
(This special issue belongs to the Section Hematology)
Clinical Progression and Treatment Outcome of Multiple Myeloma
edited by Guido Lancman, Alissa Visram and Rayan Kaedbey
submission deadline 15 Jan 2026 | 2 articles | Viewed by 2541 | Submission Open
Keywords: multiple myeloma; real-world predictors of response; sequencing; treatment selection; resistance mechanisms
(This special issue belongs to the Section Hematology)
Estrogen-Receptor Low Positive (ER-Low) Breast Cancer: A New (or Old?) World to Discover
edited by Eleonora Lai and
submission deadline 15 Jan 2026 | Viewed by 309 | Submission Open
Keywords: breast cancer; estrogen receptor low positive; treatment implications; endocrine treatment; immunotherapy; chemotherapy; translational research; clinical research
(This special issue belongs to the Section Breast Cancer)
Surgical Advances in the Management of Gastrointestinal Cancers
edited by Boris Luis Gala-López
submission deadline 15 Jan 2026 | Viewed by 89 | Submission Open
Keywords: gastrointestinal cancers; surgical innovation; multimodal therapy; precision oncology; minimally invasive surgery
(This special issue belongs to the Section Gastrointestinal Oncology)
Self-Management/Patient Activation and Self-Management Support Interventions for Cancer Survivors
edited by
submission deadline 31 Jan 2026 | 3 articles | Viewed by 2048 | Submission Open
Keywords: self-management interventions; supported self-management; health coaching; patient activation; healthy lifestyle behaviors; patient activation; cancer and cancer survivorship
(This special issue belongs to the Section Oncology Nursing)
Advances in Multiparametric MRI and Artificial Intelligence for Bladder Cancer: From Diagnosis to Personalized Treatment Strategies
edited by
submission deadline 31 Jan 2026 | Viewed by 96 | Submission Open
Keywords: multiparametric MRI; artificial intelligence; bladder cancer; diagnosis; personalized treatment strategies; prognosis
(This special issue belongs to the Section Genitourinary Oncology)
Routine Screening for Distress, Depression and Anxiety in Oncology: Where Are We Now?
edited by Daniel C. McFarland and Lee A. Kehoe
submission deadline 31 Jan 2026 | Viewed by 83 | Submission Open
Keywords: psychological distress; depression; anxiety; oncology; routine screening; cancer care; patient outcomes
(This special issue belongs to the Section Psychosocial Oncology)
Basal Cell Carcinoma: Diagnosis, Treatment and Prognosis
edited by Andrzej Bieniek
submission deadline 31 Jan 2026 | Viewed by 69 | Submission Open
Keywords: basal cell carcinoma; skin cancer; diagnostic techniques; surgical and non-surgical treatment modalities; targeted therapies; long-term management and prevention
(This special issue belongs to the Section Dermato-Oncology)
Patient-Reported Outcomes Including Health-Related Quality of Life in Cancer Clinical Trials
edited by Caroline Hamm
submission deadline 31 Jan 2026 | Viewed by 54 | Submission Open
Keywords: patient-reported outcomes; guidelines; health-related quality of life; clinical trials; ethical considerations; prognosis
(This special issue belongs to the Section Palliative and Supportive Care)
Cancer Rehabilitation: Innovations in Practice & Enhancing Survivorship Care
edited by and Sara Parke
submission deadline 15 Feb 2026 | Viewed by 414 | Submission Open
Keywords: cancer rehabilitation; physiatry; survivorship; symptom management; impairment; disability
(This special issue belongs to the Section Palliative and Supportive Care)
Adaptive Radiotherapy: Advanced Imaging for Personalised Treatment
edited by and Michael G. Jameson
submission deadline 15 Feb 2026 | Viewed by 25 | Submission Open
Keywords: adaptive radiotherapy; advanced imaging; personalized radiotherapy
Innovations in the Clinical Research of Chronic Myeloid Leukemia: From Targeted Therapies to Allogeneic Stem Cell Transplantation
edited by Jeffrey H. Lipton
submission deadline 28 Feb 2026 | Viewed by 45 | Submission Open
Keywords: chronic myeloid leukemia; tyrosine kinase inhibitors; treatment resistance; allogeneic stem cell transplantation; stem cell persistence; treatment-free remission; targeted therapies
(This special issue belongs to the Section Hematology)
Immunotherapy for Head and Neck Cancer: Biomarkers, Trials, and Transformative Outcomes
edited by
submission deadline 28 Feb 2026 | Viewed by 11 | Submission Open
Keywords: immunotherapy; head and neck cancer; biomarkers; combination therapy; clinical outcomes
(This special issue belongs to the Section Head and Neck Oncology)
Biliary Tract Cancer Updates: Advancements and Insights
edited by Kristen R. Spencer
submission deadline 15 Mar 2026 | 6 articles | Viewed by 6687 | Submission Open
Keywords: biliary tract cancer; intrahepatic cholangiocarcinoma; extrahepatic cholangiocarcinoma; gallbladder cancer; targeted therapy; immunotherapy; molecular profiling; clinical trials
(This special issue belongs to the Section Gastrointestinal Oncology)
Cost Effectiveness vs. Affordability in the Age of Targeted Drug Therapies
edited by Ramy Saleh
submission deadline 15 Mar 2026 | 3 articles | Viewed by 3545 | Submission Open
Keywords: cost-effectiveness; affordability; drugs; financial; cancers; treatment; targeted drug therapies
(This special issue belongs to the Section Health Economics)
An In-Depth Review of Desmoid Tumours
edited by
submission deadline 15 Mar 2026 | 3 articles | Viewed by 2434 | Submission Open
Keywords: desmoid tumour; desmoid-like fibromatosis; active surveillance; molecular pathogenesis; surgery and margins; radiation therapy; chemotherapy; novel treatment options; functional outcomes; quality of life
(This special issue belongs to the Section Bone and Soft Tissue Oncology)
Palliative Care in Oncology: Current Advances
edited by Olav F. Dajani, and Martin Kummen
submission deadline 15 Mar 2026 | Viewed by 45 | Submission Open
Keywords: palliative care; oncology; cancers; pain; support; well-being
(This special issue belongs to the Section Palliative and Supportive Care)
Clinical Advances and Therapeutic Challenges in Small-Cell Lung Cancer and Rare Thoracic Cancers submission deadline 20 Mar 2026 | 1 articles | Viewed by 468 | Submission Open
Keywords: pleural mesothelioma; thymic cancer; neuroendocrine thoracic tumors; small-cell lung cancer; rare tumors; thoracic cancer
(This special issue belongs to the Section Thoracic Oncology)
Clinical Management of Cervical Cancer
edited by Vanessa Samouëlian
submission deadline 31 Mar 2026 | 3 articles | Viewed by 3340 | Submission Open
Keywords: cervical cancer; surgical treatments; de-escalation; systemic treatments; immunotherapy; biomarkers; personalized treatment
(This special issue belongs to the Section Gynecologic Oncology)
Prevention, Early Detection and Management of Skin Cancer
edited by and
submission deadline 31 Mar 2026 | Viewed by 1 | Submission Open
Keywords: skin cancer; dermato-oncology; cutaneous oncology; melanoma; non-melanomatous skin cancers; basal cell carcinoma; squamous cell carcinoma; Merkel cell carcinoma; sebaceous carcinoma and other adnexal carcinomas; prevention and detection; treatment; biomarkers; immunotherapy and radiotherapy; precision medicine; UV radiation; surgery; targeted therapies
Quality of Life and Management of Pediatric Cancer submission deadline 30 Apr 2026 | 2 articles | Viewed by 2289 | Submission Open
Keywords: pediatric palliative care; oncology; quality of life; early management
(This special issue belongs to the Section Childhood, Adolescent and Young Adult Oncology)
Health Disparities and Outcomes in Cancer Survivors submission deadline 30 Apr 2026 | Viewed by 395 | Submission Open
Keywords: cancer survivorship; quality of life; social behavioral determinants of health (SBDH); health disparities; symptom management
(This special issue belongs to the Section Psychosocial Oncology)
Microsurgical Management of Chronic Cancer-Related Lymphedema
edited by Elisabeth A. Kappos and
submission deadline 30 Apr 2026 | Viewed by 19 | Submission Open
Keywords: microsurgery; chronic cancer-related lymphedema; lymphatic reconstruction; surgical techniques; quality of life
(This special issue belongs to the Section Surgical Oncology)
Health Economics in Oncology: Addressing Financial Toxicity, Value-Based Care, and Equity
edited by Marcell Csanádi
submission deadline 30 Apr 2026 | Viewed by 18 | Submission Open
Keywords: financial toxicity; cost-effectiveness; value-based care; cancer care; economic sustainability; health policy; treatment affordability; underserved populations; digital health; oncology economics
(This special issue belongs to the Section Health Economics)
PD-1 and PD-L1 in Cancer Immunotherapy submission deadline 30 Jun 2026 | Viewed by 99 | Submission Open
Keywords: PD-1; PD-L1; cancer immunotherapy; immune checkpoint inhibitors; resistance mechanisms; combination therapies
Back to TopTop